GenSight Biologics S.A. (GSGTF)
USD 0.24
(-92.26%)
USD 0.24
(-92.26%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -26.22 Million EUR | 2.19% |
| 2022 | -29.56 Million USD | 9.1% |
| 2021 | -32.52 Million USD | 21.85% |
| 2020 | -41.61 Million USD | -20.12% |
| 2019 | -34.64 Million USD | 9.39% |
| 2018 | -38.24 Million EUR | -32.08% |
| 2017 | -28.95 Million EUR | -24.31% |
| 2016 | -23.29 Million EUR | -57.03% |
| 2015 | -14.83 Million EUR | -122.33% |
| 2014 | -6.67 Million EUR | -141.46% |
| 2013 | -2.76 Million EUR | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q2 | -6.26 Million USD | 0.0% |
| 2023 Q2 | -13.04 Million USD | 0.0% |
| 2023 Q4 | -15.71 Million USD | 0.0% |
| 2023 FY | -28.91 Million USD | 2.19% |
| 2022 FY | -29.56 Million USD | 9.1% |
| 2022 Q2 | -11.22 Million USD | 0.0% |
| 2021 FY | -32.52 Million USD | 21.85% |
| 2021 Q2 | -9.84 Million USD | 0.0% |
| 2020 Q4 | -24.39 Million USD | 0.0% |
| 2020 FY | -41.61 Million USD | -20.12% |
| 2020 Q2 | -15.81 Million USD | 0.0% |
| 2019 FY | -34.64 Million USD | 9.39% |
| 2019 Q2 | -19.75 Million USD | 0.0% |
| 2019 Q4 | -15 Million USD | 0.0% |
| 2018 Q2 | -13.61 Million USD | 0.0% |
| 2018 Q4 | -24.91 Million USD | 0.0% |
| 2018 FY | -38.24 Million EUR | -32.08% |
| 2017 FY | -28.95 Million EUR | -24.31% |
| 2016 FY | -23.29 Million EUR | -57.03% |
| 2015 FY | -14.83 Million EUR | -122.33% |
| 2014 FY | -6.67 Million EUR | -141.46% |
| 2013 FY | -2.76 Million EUR | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Capstone Therapeutics Corp. | -3.81 Million USD | -586.567% |
| Skye Bioscience, Inc. | -37.64 Million USD | 30.349% |
| Santhera Pharmaceuticals Holding AG | 65.13 Million USD | 140.256% |
| Nascent Biotech, Inc. | -2.08 Million USD | -1155.938% |
| Qrons Inc. | -789.34 Thousand USD | -3221.733% |
| ProtoKinetix, Incorporated | -415.47 Thousand USD | -6210.788% |
| Adynxx, Inc. | - USD | Infinity% |
| Arch Therapeutics, Inc. | -6.98 Million USD | -275.492% |
| BioStem Technologies, Inc. | -8.48 Million USD | -209.089% |
| Regen BioPharma, Inc. | 1.02 Million USD | 2661.778% |
| CSL Limited | 2.64 Billion USD | 100.992% |
| Northwest Biotherapeutics, Inc. | -62.59 Million USD | 58.114% |
| Evofem Biosciences, Inc. | 52.97 Million USD | 149.491% |
| Rebus Holdings, Inc. | -1.02 Million USD | -2470.588% |
| Burzynski Research Institute, Inc. | -1.33 Million USD | -1863.411% |
| Neon Bloom, Inc. | -632.4 Thousand USD | -4046.064% |
| Acro Biomedical Co., Ltd. | -15.87 Million USD | -65.202% |
| Eiger BioPharmaceuticals, Inc. | -74.96 Million USD | 65.023% |
| Nanobac Pharmaceuticals, Incorporated | -6.57 Million USD | -298.716% |
| Institute of Biomedical Research Corp. | -273.4 Thousand USD | -9490.274% |
| SQZ Biotechnologies Company | -79.46 Million USD | 67.004% |
| Intellipharmaceutics International Inc. | -2.89 Million USD | -806.516% |
| Propanc Biopharma, Inc. | -1.82 Million USD | -1340.242% |
| Mesoblast Limited | -87.95 Million USD | 70.19% |
| Marizyme, Inc. | -65.34 Million USD | 59.876% |
| Genus plc | 7.9 Million USD | 431.899% |
| VioQuest Pharmaceuticals, Inc. | -10.89 Million USD | -140.733% |
| Pharming Group N.V. | -10.54 Million USD | -148.578% |
| Therapeutic Solutions International, Inc. | -2.16 Million USD | -1108.399% |
| CNBX Pharmaceuticals Inc. | -3.71 Million USD | -606.694% |
| Nymox Pharmaceutical Corporation | -8.84 Million USD | -196.472% |
| ContraFect Corporation | -65.15 Million USD | 59.756% |
| PsyBio Therapeutics Corp. | -4.88 Million USD | -436.628% |
| Sienna Biopharmaceuticals, Inc. | - USD | Infinity% |
| RegeneRx Biopharmaceuticals, Inc. | -1.72 Million USD | -1417.84% |
| IMV Inc. | -36.48 Million USD | 28.136% |
| AXIM Biotechnologies, Inc. | -8.05 Million USD | -225.323% |
| MultiCell Technologies, Inc. | -380.07 USD | -6898629.181% |
| ONE Bio Corp. | 8.67 Million USD | 402.192% |
| Accustem Sciences Inc. | -3.74 Million USD | -599.868% |
| RVL Pharmaceuticals plc | -51.69 Million USD | 49.276% |
| Arno Therapeutics, Inc. | - USD | Infinity% |
| EV Biologics, Inc. | -1.26 Million USD | -1969.237% |
| Q BioMed Inc. | -2.05 Million USD | -1177.72% |
| Emmaus Life Sciences, Inc. | -3.73 Million USD | -602.384% |
| Mosaic ImmunoEngineering Inc. | -2.38 Million USD | -1001.278% |
| Biomind Labs Inc. | -1.21 Million USD | -2059.235% |
| American Oriental Bioengineering, Inc. | -59.72 Million USD | 56.099% |
| Provectus Biopharmaceuticals, Inc. | -3.1 Million USD | -745.324% |
| TetraLogic Pharmaceuticals Corporation | - USD | Infinity% |
| Oncotelic Therapeutics, Inc. | -7.9 Million USD | -231.769% |
| GlobeStar Therapeutics Corporation | -1.94 Million USD | -1245.133% |
| THC Farmaceuticals, Inc. | -14.97 Thousand USD | -174980.128% |
| Curative Biotechnology, Inc. | -5.81 Million USD | -350.728% |
| GB Sciences, Inc. | -1.36 Million USD | -1825.567% |
| Alpha Cognition Inc. | -13.77 Million USD | -90.378% |
| HST Global, Inc. | -146.21 Thousand USD | -17833.11% |
| Wesana Health Holdings Inc. | -1.75 Million USD | -1394.212% |
| Halberd Corporation | -79.67 Thousand USD | -32808.279% |
| Enzolytics Inc. | -2.17 Million USD | -1104.503% |
| Agentix Corp. | -1.37 Million USD | -1808.004% |
| Resverlogix Corp. | -3.61 Million USD | -626.316% |
| Nuo Therapeutics, Inc. | -3.17 Million USD | -726.755% |
| MetaStat, Inc. | - USD | Infinity% |
| argenx SE | -295.05 Million USD | 91.113% |
| Enzon Pharmaceuticals, Inc. | 98 Thousand USD | 26855.102% |
| Endonovo Therapeutics, Inc. | 6.92 Million USD | 478.65% |
| RespireRx Pharmaceuticals Inc. | -3.97 Million USD | -559.956% |
| GeneThera, Inc. | - USD | Infinity% |
| Inhibitor Therapeutics, Inc. | -3.02 Million USD | -766.452% |
| AVAX Technologies, Inc. | -6.41 Million USD | -308.816% |
| Zenith Capital Corp. | -10.59 Million USD | -147.452% |
| Genscript Biotech Corporation | -95.47 Million USD | 72.538% |
| Ember Therapeutics, Inc. | -23.24 Thousand USD | -112713.011% |
| Anthera Pharmaceuticals, Inc. | - USD | Infinity% |
| Sigyn Therapeutics, Inc. | -4.14 Million USD | -532.427% |
| WPD Pharmaceuticals Inc. | -60.44 Thousand USD | -43281.428% |
| Cotinga Pharmaceuticals Inc. | -2 Million USD | -1207.656% |
| Kadimastem Ltd | -3.3 Million USD | -692.768% |
| Helix BioMedix, Inc. | -1.05 Million USD | -2382.821% |
| VitaSpring Biomedical Co. Ltd. | - USD | Infinity% |
| Oncology Pharma Inc. | - USD | Infinity% |
| Reve Technologies, Inc. | -441.36 Thousand USD | -5840.608% |
| LadRx Corporation | 400.44 Thousand USD | 6647.748% |
| Cell Source, Inc. | -5.32 Million USD | -392.745% |
| Regen BioPharma, Inc. | 1.02 Million USD | 2661.778% |
| NovAccess Global Inc. | -4.76 Million USD | -449.779% |
| Affymax, Inc. | -14.42 Million USD | -81.78% |
| Itoco Inc. | -1.86 Million USD | -1302.893% |
| Rasna Therapeutics, Inc. | -4.44 Million USD | -490.204% |
| Pathfinder Cell Therapy, Inc. | -1.66 Million USD | -1471.001% |
| Mobile Lads Corp. | -2.26 Million USD | -1058.489% |
| CytoDyn Inc. | -49.84 Million USD | 47.393% |
| Claritas Pharmaceuticals, Inc. | - USD | Infinity% |
| NDT Pharmaceuticals Inc. | -79.03 Thousand USD | -33076.015% |
| NanoSphere Health Sciences Inc. | -228.12 Thousand USD | -11393.598% |
| Alseres Pharmaceuticals, Inc. | -941.52 Thousand USD | -2684.832% |
| SYBLEU INC | -180.3 Thousand USD | -14442.107% |
| Advanced Proteome Therapeutics Corporation | - USD | Infinity% |
| ImmunoCellular Therapeutics, Ltd. | -1.61 Million USD | -1525.808% |
| International Stem Cell Corporation | -131 Thousand USD | -19915.267% |
| Bioxytran, Inc. | -4.28 Million USD | -512.617% |
| GlobeImmune, Inc. | - USD | Infinity% |
| Predictive Technology Group, Inc. | - USD | Infinity% |
| ProText Mobility, Inc. | -54.27 Thousand USD | -48212.205% |
| Cardax, Inc. | - USD | Infinity% |
| VG Life Sciences Inc. | -2.53 Million USD | -936.262% |
| Kaleido Biosciences, Inc. | - USD | Infinity% |
| Advaxis, Inc. | -48.07 Million USD | 45.457% |
| Adhera Therapeutics, Inc. | -2.11 Million USD | -1140.303% |
| RenovaCare, Inc. | - USD | Infinity% |
| Regnum Corp. | -780.88 Thousand USD | -3257.72% |
| Innovation Pharmaceuticals Inc. | -3.16 Million USD | -727.652% |
| Neutra Corp. | -233.46 Thousand USD | -11130.805% |
| Windtree Therapeutics, Inc. | -20.29 Million USD | -29.22% |
| PureTech Health plc | -65.69 Million USD | 60.09% |
| Coeptis Therapeutics, Inc. | -21.26 Million USD | -23.292% |
| IXICO plc | -1.17 Million USD | -2125.806% |
| IntelGenx Technologies Corp. | -9.92 Million USD | -164.128% |
| Gelesis Holdings, Inc. | -57.12 Million USD | 54.103% |
| CSL Limited | 2.64 Billion USD | 100.992% |
| Cellectis S.A. | -103.17 Million USD | 74.587% |